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OBJECTIVE—Chronic exposure of pancreatic -cells to satu-
rated free fatty acids (FFAs) causes endoplasmic reticulum (ER)
stress and apoptosis and may contribute to -cell loss in type 2
diabetes. Here, we evaluated the molecular mechanisms involved
in the protection of -cells from lipotoxic ER stress by glucagon-
like peptide (GLP)-1 agonists utilized in the treatment of type 2
diabetes.
RESEARCH DESIGN AND METHODS—INS-1E or ﬂuorescence-
activated cell sorter–puriﬁed primary rat -cells were exposed to
oleate or palmitate with or without the GLP-1 agonist exendin-4
or forskolin. Cyclopiazonic acid was used as a synthetic ER
stressor, while the activating transcription factor 4–C/EBP ho-
mologous protein branch was selectively activated with salu-
brinal. The ER stress signaling pathways modulated by GLP-1
agonists were studied by real-time PCR and Western blot.
Knockdown by RNA interference was used to identify mediators
of the antiapoptotic GLP-1 effects in the ER stress response and
downstream mitochondrial cell death mechanisms.
RESULTS—Exendin-4 and forskolin protected -cells against
FFAs via the induction of the ER chaperone BiP and the
antiapoptotic protein JunB that mediate -cell survival under
lipotoxic conditions. On the other hand, exendin-4 and forskolin
protected against synthetic ER stressors by inactivating caspase
12 and upregulating Bcl-2 and X-chromosome–linked inhibitor of
apoptosis protein that inhibit mitochondrial apoptosis.
CONCLUSIONS—These observations suggest that GLP-1 ago-
nists increase in a context-dependent way the -cell defense
mechanisms against different pathways involved in ER stress–
induced apoptosis. The identiﬁcation of the pathways modulated
by GLP-1 agonists allows for targeted approaches to alleviate
-cell ER stress in diabetes. Diabetes 58:2851–2862, 2009
T
he prevalence of type 2 diabetes is increasing
dramatically as a result of environmental
changes, including the adoption of Western diets
rich in saturated fats. These diets augment insu-
lin requirements but also cause early pancreatic -cell
dysfunction that is central to the pathogenesis of type 2
diabetes. Three lines of evidence support this hypothesis:
1) -Cell function is decreased before clinically detected
type 2 diabetes (1,2) (i.e., early in its natural history). 2)
Most type 2 diabetes candidate genes affect -cell mass
and/or function (3). 3) Type 2 diabetic individuals have
decreased -cell mass (4,5), secondary to increased -cell
apoptosis (4,6). The progressive nature of type 2 diabetes,
characterized by “secondary failure” requiring patients on
oral agents to switch to insulin, is due to loss of insulin
secretory capacity. This has shifted research emphasis to
the search for agents that prevent loss of functional -cell
mass by increasing proliferation and/or decreasing -cell
death.
Chronic exposure to free fatty acids (FFAs) causes
lipotoxic -cell dysfunction and death in in vitro and some,
but not all, in vivo models tested (7,8) and may contribute
to type 2 diabetes development. A growing body of evi-
dence suggests that endoplasmic reticulum (ER) stress is
one of the molecular mechanisms underlying both insulin
resistance and -cell failure (9). Saturated and, to a lesser
extent, unsaturated FFAs trigger -cell ER stress and
apoptosis (10–14) through changes in ER Ca
2 handling
and secondary protein malfolding (12).
The unfolded protein response (UPR) or ER stress re-
sponse is triggered when malfolded proteins accumulate
inside the ER (15,16). The three UPR pathways are under the
control of double-stranded RNA–activated protein kinase
(PKR)-like kinase (PERK), activating transcription factor
(ATF) 6, and inositol requiring-1 (IRE1) (online appendix
Fig. S1 [available at http://diabetes.diabetesjournals.
org/cgi/content/full/db09-0685/DC1). The main purpose
of the UPR is to restore ER homeostasis by decreasing ER
protein load and increasing ER folding capacity (16).
PERK phosphorylates the eukaryotic translation initiation
factor 2 (eIF2), leading to attenuation of global transla-
tion and, paradoxically, enhanced expression of selected
proteins including ATF4. ATF4 induces C/EBP homolo-
gous protein (CHOP; also known as GADD153 or DDIT3)
and downstream GADD34. The translational inhibition of
the UPR is transitory, as GADD34 acts as a substrate-
targeting factor to protein phosphatase 1 (PP1) to dephos-
phorylate eIF2 (17). Activated ATF6 induces transcription
of ER chaperones including BiP (18). IRE1 splices X-box
binding protein 1 (XBP1) mRNA, leading to the translation
of the active transcription factor XBP1s that induces ER
chaperones and ER-associated protein degradation (19).
IRE1 degrades mRNAs for some highly translated proteins
including insulin (20), thereby decreasing demand on the
ER. IRE1 also recruits tumor necrosis factor receptor–
associated factor (TRAF) 2 and apoptosis signal–regulat-
ing kinase (ASK) 1, which activate JNK (21); it can activate
caspase 12 (22) and interact with pro- and antiapoptotic
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mediated apoptosis.
Increased ER stress signaling is found in islets from type
2 diabetic patients, including expression of ATF3, CHOP,
and BiP; nuclear localization of CHOP; and -cell ER
expansion (9). The stress response has also been impli-
cated in young-onset diabetes. Proinsulin gene mutations
cause insulin malfolding (23), and PERK (24) and Wolfram
Syndrome-1 mutations (25) affect proper ER stress signal-
ing, all of which culminate in -cell loss. Agents that
modulate the -cell ER stress response will therefore have
immediate therapeutic application.
We have previously examined the usefulness of salu-
brinal, a selective inhibitor of eIF2 dephosphorylation,
shown to protect against ER stress–mediated apoptosis
(26). Unexpectedly, salubrinal-induced eIF2 phosphory-
lation was proapoptotic in -cells, and it potentiated the
deleterious effects of FFAs (11). Prolonged CHOP induc-
tion is proapoptotic in rodent models of ER stress and
diabetes (27) and in FFA-treated -cells (12) and mediates
the deleterious salubrinal effects through ampliﬁed ATF4-
CHOP signaling (11).
Exendin-4 is a glucagon-like peptide (GLP)-1 receptor
(GLP-1R) agonist used in the treatment of type 2 diabetes
(28). Exendin-4 and forskolin have previously been re-
ported to improve -cell survival following ER stress
induced by the synthetic stressors thapsigargin or tunica-
mycin (29). This cAMP-protein kinase A (PKA)-dependent
protection was apparently mediated through enhanced
ATF4-CHOP-GADD34 signaling, resulting in eIF2 dephos-
phorylation and translational recovery (29).
We demonstrate here that exendin-4 and forskolin pro-
tect -cells against FFA- and salubrinal-induced ER stress
and apoptosis, not through ATF4-CHOP-GADD34 feed-
back signaling but by enhancing cellular defense mecha-
nisms (e.g., BiP, Bcl-2, and JunB). The identiﬁcation of
these ER stress signals modulated by GLP-1 may allow
tailored approaches to alleviate ER stress in human dia-
betes and prevent progressive loss of functional -cell
mass.
RESEARCH DESIGN AND METHODS
Culture of primary ﬂuorescence-activated cell sorter–puriﬁed rat
-cells, INS-1E cells, and human islets. Male Wistar rats (Charles River
Laboratories, Brussels, Belgium) were housed and used according to the
guidelines of the Belgian Regulations for Animal Care; experiments were
approved by the local ethics committee. Islets were hand picked following
collagenase digestion. -Cells were puriﬁed from dispersed islet cells by
autoﬂuorescence-activated cell sorting (FACSAria; BD Bioscience, San Jose,
CA) (30). The preparations, containing 91  2% -cells, were precultured
overnight in Ham’s F-10 medium containing 10 mmol/l glucose and 5%
heat-inactivated FBS (31).
The rat insulin–producing INS-1E cell line (a kind gift from Prof. C.
Wollheim, Centre Medical Universitaire, Geneva, Switzerland) was cultured in
RPMI-1640 (with 2 mmol/l GlutaMAX-I) containing 5% FBS (32) and used at
passages 56–75.
With the approval of the ethics committee in Pisa, islets of four multiorgan
donors (two female and two male subjects, aged 64  10 years, BMI 26  1
kg/m
2) were isolated, and cultured as previously described (12). The human
islets contained 58  2% -cells, assessed following islet dispersion (12).
Treatments. For FFA exposure, -cells were cultured in medium with 1%
BSA and without FBS; INS-1E cells were cultured in medium with 1% FBS and
1% BSA. Oleate and palmitate (Sigma-Aldrich, Schnelldorf, Germany) were
dissolved in 90% ethanol and used at a ﬁnal concentration of 0.5 mmol/l (10,33)
and a FFA/BSA molar ratio of 3.4 (33). The sarcoendoplasmic-reticulum pump
Ca
2-ATPase (SERCA) blockers cyclopiazonic acid (CPA) and thapsigargin
(Sigma) were dissolved in DMSO and used at concentrations of 25 and 1
mol/l, respectively. Salubrinal (ChemBridge, San Diego, CA) was diluted in
DMSO and used at 75 mol/l. Tautomycin was diluted in ethanol and used at
30 nmol/l. Exendin-4 was diluted in RPMI-1640 and used at 10 nmol/l for
primary cells and 50 nmol/l for INS-1E cells (29). Forskolin and the PKA
inhibitor H89 were diluted in DMSO and used at concentrations of 20 and 15
mol/l, respectively (Sigma).
Assessment of -cell viability and apoptosis pathways. Apoptotic and
necrotic -cells and INS-1E cells were counted in ﬂuorescence microscopy
following staining with the DNA-binding dyes propidium iodide (5 g/ml) and
Hoechst 33342 (10 g/ml) (11). The percentage human islet cell death was
determined as described (12). The apoptosis index was calculated as [(%
apoptosis in ER stressor–treated cells under indicated conditions transfected
with negative or target siRNA  % apoptosis in ER stressor–treated negative
siRNA-transfected cells)/(100%  % apoptosis in ER stressor–treated negative
siRNA-transfected cells)]  100. Apoptosis was also assessed by the Cell
Death Detection ELISA
plus kit (Roche Diagnostics, Mannheim, Germany) (10).
Forskolin did not modify INS-1E cell proliferation under the present experi-
mental conditions (assessed by BrdU incorporation, data not shown).
To study cytochrome C release, cells were prepared as described in the
online appendix supplementary Methods. After total protein quantiﬁcation
(Bio-Rad Laboratories, Munchen, Germany), equal amounts of protein were
blotted using tubulin as cytoplasmic and apoptosis-inducing factor (AIF) as
mitochondrial control.
Caspase 3 and 7 activation was measured with the Caspase-Glo 3/7 assay
(Promega, Madison, WI) and caspase 12 activation with the CaspGlow
Caspase-12 staining kit (Biovision, Mountain View, CA) (12).
Real-time PCR, Western blot, and RNA interference. Real-time PCR and
Western blot were performed as described in the online appendix supplemen-
tary Methods.
Proteins were knocked down using small-interfering RNA (siRNA) against
CHOP (Ambion, Austin, TX), XBP1, JunB (both from Invitrogen, Carlsbad,
CA), GADD34, and BiP (both from Dharmacon, Chicago, IL). A negative
control of 21-nucleotide duplex RNA with no known sequence homology was
from Qiagen (Hilden, Germany). Lipid-RNA complexes were formed in
Optimem1 (1 l Dharmafect to 150 nmol/l siRNA; Dharmacon) and added at
a ﬁnal concentration of 30 nmol/l siRNA for transfection as described (12).
Transfected cells were cultured for 1–4 days and subsequently treated.
Statistical analysis. Data are presented as means  SE. Comparisons were
performed by ANOVA followed by paired t test with the Bonferroni correction
for multiple comparisons. A P value 0.05 was considered statistically
signiﬁcant.
RESULTS
Exendin-4 and forskolin protect -cells from chemi-
cal and physiological ER stressors. In agreement with
Yusta et al. (29), exendin-4 partially protected primary and
clonal -cells against the chemical SERCA2 blockers CPA
and thapsigargin, and the adenylate cyclase stimulator
forskolin had a similar effect (Fig. 1A and E).
We next examined whether GLP-1R activation protects
-cells against the physiologically relevant ER stressors
oleate and palmitate (10–14). We also asked whether
GLP-1 is antiapoptotic following selective activation of the
PERK pathway. To this end, we used salubrinal, an inhib-
itor of eIF2 dephosphorylation (26) that, without causing
ER stress, markedly upregulates ATF4 and CHOP and
thereby triggers -cell apoptosis (11). Exendin-4 and for-
skolin protected primary - and INS-1E cells against oleate
and palmitate after 14–24 h (Fig. 1B and F), in keeping
with previous reports (34,35), but the protection against
palmitate was lost following prolonged exposure (Fig. 1C
and G). GLP-1R activation protected human islets against
palmitate for 72 h (Fig. 1D). GLP-1 agonists also prevented
salubrinal-induced -cell death (Fig. 1B and F). The ﬁnd-
ings were conﬁrmed using an enzyme-linked immunosor-
bent assay for DNA strand breaks (Fig. 1H).
Exendin-4 and forskolin do not protect -cells
through ATF4-CHOP-GADD34–mediated eIF2 de-
phosphorylation. In clonal -cells exposed to synthetic
ER stressors, exendin-4 induces ATF4 and CHOP, thereby
upregulating GADD34 (29). The recruitment of PP1 by
GADD34 results in eIF2 dephosphorylation, and this
was proposed to accelerate recovery from ER stress
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lin did not modify ATF4 and CHOP mRNA (Fig. 2A and
supplementary Fig. S2A), but after 14 h, ATF4 and CHOP
protein expression doubled in palmitate-treated cells
(Fig. 2B), and this induced GADD34 mRNA (Fig. 2A).
When combined with salubrinal, per se, a potent ATF4-
CHOP inducer (11), forskolin further upregulated ATF4-
CHOP-GADD34 RNA and protein (Fig. 2 and supple-
mentary Fig. S2).
We next examined whether this GADD34 induction
causes eIF2 dephosphorylation. Exendin-4 and forskolin
effectively decreased salubrinal-induced eIF2 phosphor-
ylation in INS-1E cells (Fig. 2C and supplementary Fig.
S2C) and tended to decrease palmitate-induced eIF2
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FIG. 1. Exendin-4 and forskolin protect -cells against ER stress–mediated apoptosis. Primary rat -cells (A–C), human islets (D), or INS-1E cells
(E–H) were left untreated (C) or treated with 25 mol/l CPA, 1 mol/l thapsigargin, 0.5 mmol/l oleate (O) or palmitate (P), or 75 mol/l
salubrinal (S), alone (control, ) or in combination with exendin-4 (10 nmol/l for primary cells or 50 nmol/l for INS-1E cells, f) or forskolin (20
mol/l, u) for 14 h (F), 24 h (A, B, E, G, and H), and 3 days (C and D). Apoptosis was measured by ﬂuorescence microscopy (A–G)o r
enzyme-linked immunosorbent assay (H). Results represent means  SE of 3–11 independent experiments. *P < 0.05 for the comparison against
untreated cells; #P < 0.05.
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FIG. 2. Exendin-4 or forskolin increases signaling downstream of PERK. INS-1E cells were cultured in the presence or absence of 0.5 mmol/l
oleate (O) or palmitate (P) or 75 mol/l salubrinal (S), alone or in combination with 50 nmol/l exendin-4 (E) or 20 mol/l forskolin (F) for the
indicated times (D)o r1 4h( A–C and E). , control; f, exendin-4; u, forskolin. ATF4, CHOP, and GADD34 mRNA expression was analyzed by
real-time PCR, normalized for the expression level of the housekeeping gene GAPDH (A). ATF4 and CHOP (B) and phospho-PERK (E) protein
expression was analyzed by Western blot, normalized for the expression level of -actin, and expressed as fold induction of control. eIF2
phosphorylation (C and D) was normalized for total eIF2. Results represent means  SE of 3–5 independent experiments. *P < 0.05 against
untreated cells; #P < 0.05.
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by siRNA (55% decrease in mRNA) increased eIF2 phos-
phorylation by 75% in salubrinal plus forskolin–treated
INS-1E cells (14 h, n 	 3). A detailed time-course analysis
revealed that very early on (1 h), forskolin diminished
eIF2 phosphorylation by salubrinal (Fig. 2D), suggesting
that forskolin immediately affects eIF2 phosphorylation,
in addition to enhancing its dephosphorylation via ATF4-
CHOP-GADD34. The effect of exendin-4 and forskolin on
eIF2 was not PERK dependent, as phospho-PERK was
unchanged or even increased (Fig. 2E and supplementary
Fig. S2D). To examine whether GADD34-PP1 dephosphor-
ylation of eIF2 mediates the antiapoptotic effect of
forskolin, we used the PP1 inhibitor tautomycin (36). In
the presence of tautomycin, forskolin did not prevent
eIF2 phosphorylation by salubrinal (Fig. 3A). Despite the
high phospho-eIF2 levels, forskolin still protected against
salubrinal-induced apoptosis (Fig. 3B), suggesting that the
eIF2 phosphorylation state does not determine forskolin-
mediated -cell survival. To further evaluate the participa-
tion of ATF4-CHOP-GADD34 in the forskolin protection,
the feedback loop was interrupted by RNAi. CHOP knock-
down prevented CHOP protein induction by palmitate/
salubrinal plus forskolin (Fig. 3C and F) and decreased
GADD34 mRNA (Fig. 3D and G), demonstrating efﬁcient
disruption of CHOP-GADD34 signaling. Decreasing CHOP
expression partially prevented palmitate-induced (12) and
salubrinal-induced apoptosis (Fig. 3E and H). The anti-
apoptotic effect of forskolin was unaffected by knockdown
of CHOP (Fig. 3E, H, and I) or GADD34 (8  1% apoptosis
vs. 6  1% with control siRNA following salubrinal plus
forskolin exposure, compared with 18–22% after salu-
brinal exposure, 14 h, n 	 3), strongly arguing against their
participation in -cell protection. CHOP knockdown did
not abrogate the forskolin protection against CPA (supple-
mental Fig. S3), casting doubt onto its proposed impor-
tance for GLP-1 protection against ER stress (29).
Exendin-4 and forskolin-induced XBP1 splicing does
not mediate protection from ER stress. We next exam-
ined the potential involvement of the other ER stress
branches in the protective effects of GLP-1 (supplemen-
tary Fig. S1). Exendin-4 and forskolin upregulated XBP1s
mRNA and protein in INS-1E cells basally (Fig. 4 and
supplementary Fig. S4), suggesting that GLP-1R agonists
activate IRE1, but they did not enhance the XBP1s induc-
tion by FFAs (Fig. 4). Similar changes were observed for
ORP150 mRNA, a XBP1s transcriptional target (data not
shown).
The role of XBP1s in -cell death was studied using
RNAi, resulting in 74% decreased XBP1 protein expres-
sion. XBP1s knockdown increased apoptosis by oleate
(Fig. 4C) but not palmitate or salubrinal (Fig. 4E and G),
illustrating that the signaling response engaged by differ-
ent ER stressors has context-dependent cell survival out-
comes (supplementary Fig. S8A). The antiapoptotic effect
of forskolin in oleate-, palmitate-, and salubrinal-treated
cells did not depend on XBP1s expression, as XBP1
knockdown did not abrogate its protective effect (Fig. 4H).
BiP induction by exendin-4 and forskolin contributes
to the protection against palmitate. BiP is a key
ATF6-dependent ER chaperone. Exendin-4 and forskolin
doubled BiP protein levels in FFA-treated INS-1E cells;
mRNA induction was observed for oleate only (Fig. 5A–C
and supplementary Fig. S4). Conversely, forskolin induced
BiP mRNA but not protein in salubrinal-exposed cells (Fig.
5 and supplementary Fig. S4), pointing to posttranscrip-
tional regulation. Forskolin also increased basal BiP pro-
tein (Fig. 5C and supplementary Fig. S4C). BiP protein
induction by forskolin was conﬁrmed in primary -cells
(Fig. 5D and supplementary Fig. S4D). p58
IPK mRNA
levels, another ATF6 target, were comparable to BiP (data
not shown).
The role of BiP induction in -cell survival was exam-
ined by RNAi. The relatively modest 50% BiP knockdown
(Fig. 5E and G) is probably due to the marked BiP stability
in INS-1E cells (data not shown). BiP knockdown in-
creased apoptosis induced by oleate and palmitate (Fig. 5F
and H and supplementary Fig. S8A), which is in keeping
with the reverse experiment showing palmitate resistance
in BiP-overexpressing cells (13). The antiapoptotic action
of forskolin was not affected by interference with BiP in
oleate-exposed cells (Fig. 5F), but a marked loss of
protection against palmitate was observed (Fig. 5H and I),
showing that BiP induction is one of the mechanisms by
which GLP-1 protects against ER stress.
To further elucidate the mechanisms of -cell protec-
tion, we examined the apoptosis pathways downstream of
ER stress that can be ER speciﬁc or employ the classic
intrinsic mitochondrial cell death pathway.
GLP-1R activation induces antiapoptotic proteins
and prevents mitochondrial caspase-mediated cell
death. To assess the contribution of mitochondria in the
apoptotic process, mitochondrial cytochrome C release
and the antiapoptotic protein Bcl-2 were measured. Palmi-
tate and salubrinal decreased Bcl-2 and stimulated cyto-
chrome C release, as did CPA (Fig. 6 and supplementary
Fig. S5) but not oleate (data not shown). Both exendin-4
and forskolin restored Bcl-2 protein to control levels in
salubrinal-treated cells (Fig. 6C and supplementary Fig.
S5B) and thereby largely prevented cytochrome C release
(Fig. 6B and supplementary Fig. S5A). It has been sug-
gested that CHOP mediates Bcl-2 downregulation (37), but
we did not observe changes in Bcl-2 expression following
CHOP knockdown (data not shown). In palmitate-treated
-cells, no restoration of Bcl-2 expression was observed,
while forskolin increased Bcl-2 levels in control and oleate
conditions (Fig. 6 and supplementary Fig. S5).
Cytochrome C released from the mitochondria binds to
the proapoptotic protease-activation factor 1 (APAF1) and
caspase 9, constituting the apoptosome that activates the
effector caspase 3 (38). This is counteracted by X-chromo-
some–linked inhibitor of apoptosis (XIAP), a potent
caspase inhibitor that binds to caspase 9 or 3 (39). XIAP
mRNA was not modiﬁed (data not shown), but as with
Bcl-2 XIAP protein expression was reduced by palmitate,
salubrinal, and CPA (Fig. 6C and supplemental Fig. S5C).
Again, exendin-4 and forskolin restored XIAP levels in
salubrinal- and CPA-treated cells but not in palmitate-
treated cells (supplemental Fig. S5C).
In keeping with the restoration of Bcl-2 and XIAP and
the inhibition of cytochrome C release, caspase 3 activa-
tion was nearly entirely prevented by exendin-4 and fors-
kolin in salubrinal- or CPA-treated -cells (Fig. 6D).
Exendin-4 and forskolin partially reduced caspase 3 acti-
vation by palmitate, but residual activity remained three-
to fourfold above control (Fig. 6D).
During ER stress, caspase 3 can also be activated by
caspase 12 (40). FFAs and CPA activate ER membrane–
localized caspase 12 in -cells (12). Exendin-4 or forskolin
did not modify caspase 12 activation in FFA-treated cells
but abolished its activation by CPA (Fig. 6E). This repre-
sents an additional mechanism through which GLP-1 can
D.A. CUNHA AND ASSOCIATES
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role in physiological ER stress.
JunB protects -cells against FFAs and plays a major
role in the antiapoptotic effects of GLP-1R activa-
tion. The transcription factor JunB was recently shown to
be antiapoptotic in -cells exposed to chemical ER stres-
sors (41). JunB protein expression was downregulated by
CPA, palmitate, and salubrinal but not by oleate (Fig. 7A
and supplemental Fig. S6). Exendin-4 restored JunB pro-
tein to control levels, and forskolin further induced JunB
by two- to ﬁvefold (Fig. 7A and supplemental Fig. S6). This
marked induction was not observed at the mRNA level
(data not shown). Forskolin also induced JunB protein in
primary -cells by threefold (Fig. 7B and supplemental Fig.
S6B).
An 85% JunB knockdown by siRNA (Fig. 7C, E, and G)
sensitized INS-1E cells to oleate (Fig. 7D). The protection
by forskolin against oleate was abolished in JunB-depleted
cells demonstrating that cAMP-stimulated JunB induction
is necessary and sufﬁcient to prevent cell death (Fig. 7D
(P) or salubrinal (S), alone or in combination with forskolin (F). Data are means  SE of four independent experiments. I: Data from E and H
are presented as apoptotic index. Negative index values indicate protection against apoptosis by CHOP siRNA (o), forskolin (u), or the
combination of both (f). The lack of difference between CHOP siRNA  forskolin and forskolin illustrates that CHOP does not contribute to the
protective effect of forskolin against palmitate or salubrinal. *P < 0.05 against untreated cells; #P < 0.05.
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observed with JunB knockdown, though it was partial only
(Fig. 7F). Salubrinal-induced apoptosis was not modiﬁed
by JunB knockdown, and neither was the antiapoptotic
effect of forskolin (Fig. 7H and I).
Finally, we examined whether the upregulation of these
antiapoptotic proteins by exendin-4 and forskolin was
PKA dependent. The PKA inhibitor H89 prevented BiP,
JunB, and Bcl-2 protein induction basally and following
palmitate treatment (supplemental Fig. S7A) and abro-
gated the protective effect of forskolin (supplemental Fig.
S7B).
DISCUSSION
Lipotoxic ER stress–mediated -cell dysfunction and apo-
ptosis may be relevant in the development of type 2
diabetes (9). Therapies that increase -cell resistance to
FFAs and ER stress could have considerable clinical
impact, as they might prevent type 2 diabetes or attenuate
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agonists such as exendin-4 induce cAMP-PKA, extracellu-
lar signal–regulated kinase 1/2 mitogen-activated protein
kinase, and phosphoinositide 3 kinase-Akt signaling, lead-
ing to improved -cell function through increased insulin
biosynthesis and secretion, -cell proliferation (at least in
rodents), and decreased -cell death (28,42). It has re-
cently been shown that GLP-1R activation also stimulates
-cell survival during ER stress. In rodent models, ex-
endin-4 treatment decreased in vivo pancreatic expression
of CHOP, XBP1s, and BiP (29,43), but detailed in vitro
studies demonstrated that GLP-1R activation leads to a
cAMP-PKA–dependent enhancement of ATF4-CHOP-
GADD34 signaling, followed by PP1-mediated eIF2 de-
phosphorylation and accelerated recovery of translational
repression (29). Since ER stress signaling and outcomes
are stimulus dependent, we examined whether these
mechanisms mediate GLP-1R protection from the more
pathophysiologically relevant lipotoxic ER stress. We ob-
served that the protective mechanisms previously de-
scribed for synthetic ER stress (29) are not operative in
this ER stress condition and that exendin-4 and forskolin
reduce FFA-induced apoptosis by increasing -cell de-
fense mechanisms.
The PERK-regulated ER stress branch that modulates
global protein translation is necessary for -cell survival.
Humans and/or mice with a PERK deletion or Ser51Ala
substitution in eIF2 (precluding its phosphorylation by
PERK) cannot attenuate insulin translation and have pro-
gressive -cell loss (24,44,45), suggesting that PERK-de-
pendent eIF2 phosphorylation is beneﬁcial to -cells.
Excessive or prolonged eIF2 phosphorylation and down-
stream signaling is, however, poorly tolerated by -cells
and speciﬁcally exacerbates FFA-induced apoptosis (11).
We therefore asked whether increased signaling in the
PERK pathway by exendin-4 during lipotoxic ER stress
would be pro- or antiapoptotic. The present and previous
(29) data support the idea that exendin-4 and forskolin
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however, explain the antiapoptotic outcome because
CHOP or GADD34 knockdown, or chemical PP1 inhibi-
tion, do not abrogate the protective effect of forskolin in
lipotoxic or synthetic ER stress conditions (Fig. 3 and
supplementary Fig. S3). We therefore undertook a search
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GLP-1R activation in lipotoxic ER stress.
Activation of IRE1 leads to the expression of XBP1s that
induces ER chaperones and ER expansion; for the latter
lipid synthesis genes are upregulated. The induction of
XBP1s by exendin-4 and forskolin suggests that these
agents activate IRE1, either directly or by triggering a mild
UPR (through enhanced protein synthesis) with activation
of IRE1 but not PERK. GLP-1 and high glucose mildly
activate IRE1 (46), and chronic exposure to high glucose
causes XBP1s induction in -cells that is not accompanied
by ATF4 or CHOP expression (46,47). Knockdown of
XBP1s leads to a small decrease in -cell viability (present
data). XBP1 RNAi potentiated oleate- but not palmitate-
induced -cell apoptosis (Fig. 4H and supplementary Fig.
S8A), suggesting differential activation of pro- and anti-
apoptotic signals by the FFAs downstream of IRE1; more-
over, XBP1s might play a role in oleate handling. The
prosurvival effect of forskolin was not altered by XBP1
knockdown, excluding it plays part in the observed
protection.
IRE1 activation can directly cleave caspase 12. GLP-1
agonists did not modify caspase 12 cleavage by FFAs but
nearly completely prevented its activation by CPA. In
parallel, forskolin increased CPA-mediated PERK phos-
phorylation, suggesting that ER stress is not improved in
this condition but that UPR transducers can be differen-
tially regulated by GLP-1. ER stress can trigger apoptosis
via the mitochondrial pathway of cytochrome C release,
formation of the apoptosome, and caspase 3 activation.
eIF2 phosphorylation is essential to proteasome degra-
dation of antiapoptotic Bcl-2 family members during
chemical ER stress (48). We currently observed that
palmitate, but not oleate, induced degradation of Bcl-2 and
cytochrome C release. eIF2 phosphorylation by salu-
brinal and CPA also decreased Bcl-2 with consequent
cytochrome C translocation. The repression of eIF2
phosphorylation by exendin-4 and forskolin may restore
Bcl-2 expression and thus prevent cytochrome C release
and caspase 3 activation by salubrinal and CPA, but they
have little effect on palmitate-induced apoptosis. GLP-1R
activation also restored the antiapoptotic protein XIAP in
cells exposed to salubrinal or CPA but not to palmitate,
delineating context-dependent mechanisms of GLP-1R–
mediated antiapoptotic effects (supplementary Fig. S8B).
BiP is an ATF6-dependent ER chaperone and a master
regulator of UPR activation. GLP-1 agonists doubled BiP
expression in a PKA-dependent manner, while a 50%
reduction in BiP expression sensitized -cells to FFAs,
conﬁrming the role of ER stress in lipotoxic -cell apopto-
sis. The upregulation of BiP by forskolin protected -cells
against palmitate, as the protection was partially lost
following BiP knockdown (Fig. 5I). Conclusive demonstra-
tion for the role of BiP will come from studies examining
whether GLP-1 agonists are protective over and above
adenovirus-mediated BiP overexpression. GLP-1R activa-
tion thus increases -cell protein folding capacity and
defense mechanisms against lipotoxic ER stress, prompt-
ing us to examine the potential contribution of other
antiapoptotic proteins.
GLP-1 was previously shown to induce several early
response genes in INS-1 cells, among which was JunB (49).
JunB was recently shown to play a protective role in
ER-stressed -cells (41). Palmitate, salubrinal, and CPA
decreased JunB expression, which was restored and fur-
ther increased by exendin-4 and forskolin (supplementary
Fig. S6). This PKA-dependent JunB induction is an impor-
tant promoter of -cell survival since JunB RNAi sensi-
tized cells to FFAs and it abrogated the antiapoptotic
effect of GLP-1R activation.
GLP-1 analogs provide hope that the natural history of
type 2 diabetes can be modiﬁed by the preservation of
functional -cell mass (28). We demonstrate here that
exendin-4 and cAMP production protect -cells against ER
stress in a context-dependent manner. Lipotoxic -cell
apoptosis is prevented by increasing cellular defense
mechanisms through the induction of the ER chaperone
BiP and the antiapoptotic protein JunB, whereas protec-
tion from synthetic ER stressors occurs via inactivation of
caspase 12 and upregulation of Bcl-2 and XIAP to block
mitochondrial apoptosis (supplementary Fig. S8). The
present identiﬁcation of the proapoptotic ER stress path-
ways and downstream signaling modulated by GLP-1 is an
important milestone for the development of targeted ap-
proaches to alleviate -cell ER stress in diabetes.
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